Rivaroxaban (Xarelto): Treatment of Venous Thromboembolic Events (Deep Vein Thrombosis [DVT], Pulmonary Embolism [PE]) and Prevention of Recurrent DVT and PE

Pas encore traduit Pas encore traduit
Catégorie Systematic review
LivreCADTH Common Drug Reviews
Year 2015

Cet article inclut 4 Primary studies 2 Primary studies (4 references)

This article is part of the following matrixes of evidence:
Loading references information
The objective of this report is to perform a systematic review of the beneficial and harmful effects of rivaroxaban 15 mg and 20 mg for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
Epistemonikos ID: 8088d2cbc9be3ca03a378024c549880b2fc6109f
First added on: Jul 06, 2016